Hypoprothrombinemia is a serious adverse effect of antimicrobial therapy that occurs after administration of some second-and third-generation cephalosporins which contain the methyltetrazole-thiol (MTT) group. Previous studies have shown that in vitro MTT directly inhibits microsomal y-carboxylation of a synthetic pentapeptide. Since MTT is a thiocarbamide, a type of compound that can increase oxidation of glutathione, the present studies were carried out to determine whether alterations in hepatic glutathione redox state might interfere with vitamin K metabolism.
Introduction
Hypoprothrombinemia occurs in some patients treated with f3-lactam antibiotics containing the methyltetrazole-thiol (MTT)' group (1) . This group is contained in cefamandole, moxalactam, cefoperazone, and other second-and third-generation cephalosporins (Fig. 1) . In some instances, clinically significant bleeding episodes have occurred, particularly in patients who are fasting, malnourished, immediately postoperative, or have decreased renal function (1) .
The mechanism for development of hypoprothrombinemia after administration of MTT-containing antibiotics is the subject of controversy. Some investigators have speculated that the effect is related to alterations in colonic flora which result in vitamin K deficiency (2) . Another hypothesis is that these drugs inhibit the vitamin K-dependent step in clotting factor synthesis, the y-carboxylation of glutamic acid (3, 4) .
Failure of carboxylation of the clotting factors could be due either to inhibition of vitamin K metabolism and/or direct inhibition of the carboxylation reaction. Metabolism of vitamin K includes a cycle that involves reduction of vitamin K, (a quinone), to a hydroquinone, oxidation of the hydroquinone to an epoxide, and finally the reduction ofthe epoxide to vitamin K1 (5) .
Previous studies have shown that MTT inhibits in vitro microsomal -y-carboxylation of a synthetic peptide (Phe-LeuGlu-Glu-Ile) (3, 4) . This finding suggests that the MTT group, or an active metabolite ofthis compound might be responsible for the anticoagulant effects. The finding of increased vitamin K epoxide in plasma of patients treated with moxalactam and cefamandole is consistent with an inhibition of the reduction of vitamin K epoxide (6) , an effect which cannot be due to vitamin K deficiency.
MTT is a thiocarbamide, a class of compounds which may be metabolized by a flavin-containing monoxygenase to more reactive intermediates, such as sulfenic acids (7) . Krieter and his colleagues (8) have shown that infusion of thiocarbamides into the isolated perfused rat liver causes in nonenzymatic oxidation of reduced glutathione (GSH) to oxidized glutathione (GSSG) with subsequent release of GSSG into bile (8) . Such alterations in the ratio of GSH to GSSG may effect the activity of various enzymes (8) (9) (10) (11) (12) . Under physiologic conditions, the ratio of GSH to GSSG is tightly controlled, but after pharmacologic intervention, large shifts can occur.
The present studies were carried out to evaluate whether MTT-containing antibiotics could inhibit vitamin K metabolism through effects on the hepatic thiol/disulfide ratio. Changes in the hepatic content of GSSG and vitamin K1 ,2,3-epoxide were measured to provide evidence that MTT-containing antibiotics alter both the heaptic thiol redox state and vitamin K metabolism in vivo. The effects of GSSG on microsomal reduction of vitamin K1,2,3-epoxide were studied to 
Methods
Microsomal y-carboxylation ofglutamic acid residues. Rat liver microsomes were prepared for determination of the carboxylation of glutamic acid by the method of Houser et al. (14) with the previously described modifications (3). In brief, reactions were carried out in buffer containing 25 mM imidazole, 250 mM sucrose, and 20 mM KCl, pH 7.4 , which contained the following substrates: Biliary efflux ofGSSG after administration ofMT and antibiotics to intact rats. Male Sprague-Dawley rats weighing 250-300 g were allowed free access to food and water until the morning of each experiment. Animals were anesthetized with pentobarbital 50 mg/kg i.p., and a midline laparotomy performed. The common bile duct was isolated and cannulated with PE-IO tubing. After closure of the incision, the rats were allowed to recover for 10-30 min. Timed aliquots of bile were collected into tared microfuge tubes containing 5% metaphosphoric acid for 1 h. Antibiotics and MTT were dissolved in 0.9% saline and injected into the femoral vein. Bile was collected for 80 min after administration of test compounds, and flow was determined gravimetrically. After centrifugation to remove precipitated protein, bile was assayed for GSSG and "total" GSH (reduced GSH + GSSG) as described (15) . A specific assay for GSSG monitored the oxidation of NADPH at 340 mm in the presence of glutathione reductase. Total GSH was measured using the NADPH glutathione reductase coupled oxidation of 5,5'-dithio-bis(2-nitrobenzoic acid) (DTNB) monitored at 412 nm.
Hepatic concentrations ofglutathione after administration of cefamandole. Male Sprague-Dawley rats weighing 200-250g, allowed free access to food and water, were anesthetized with sodium pentobarbital 50 mg/kg of i.p. The abdomen was opened and the liver was rapidly freeze-clamped with aluminum tongs precooled in liquid nitrogen. Frozen tissue was pulverized under liquid nitrogen and extracted with 5-10 vol of perchloric acid, 2mM EDTA for total glutathione (reduced + oxidized) or 1.0 M perchloric acid containing 2 mM EDTA and 50 mM N-ethylmaleimide for GSSG. For analysis of total glutathione, extracts were diluted into 100 mM sodium phosphate buffer, pH 7.5 and assayed as described above. For analysis of GSSG, the acid extract was carefully neutralized with 2.0 M KOH containing 0.3 M 3-[Nmorpholino]-propanesulfonic acid as described (15) . Neutralized supernatants were extracted on solid-phase C1 8 columns (Bakerbond, J. T. Baker, Inc., Phillipsburg, NJ). Columns were washed with 1.0 ml of 100 mM sodium phosphate buffer, pH 6.0. Removal of N-ethylmaleimide was verified by checking the optical density at 315 nm. GSSG was assayed using the DTNB recycling assay as described above. Recovery was > 90% routinely. methanol were 7.6, and 5.0 min, respectively. Peaks were detected at 254 and at 220 nm using a Spectromonitor III (Lab Data Control, Riviera Beach, FL), or a diode array detector (LKB, Uppsala, Sweden). Quantitation was carried out by integration of peak areas using a recording integrator (Hewlett-Packard Co., Palo Alto, CA).
Preparation of KH2 by reduction of vitamin K,. Vitamin K1 was reduced chemically by sodium dithionite (hydrosulfite) as described (17) . Reduction was confirmed by UV spectral analysis just before use.
Microsomal reduction of vitamin K,2,3-epoxide. Rat hepatic microsomes were prepared using a modification of the method described (18) in which the microsomal pellet was suspended in 25 mM imidazole, pH 7.2, containing 0.5% 3-[(3-cholamidopropyl)-dimethylammonio]-l-propanesulfonate (CHAPS) and diluted to a concentration of 10 mg of microsomal protein/ml. Vitamin K epoxide reductase activity was assayed by a modification of the method of Wallin and Martin (19) . The solubilized microsomal fraction was incubated with varying concentrations of vitamin K1 ,2,3-epoxide in the presence of 0.1-5.0 mM DTT at 22°C for 30 min. The reaction was terminated by the addition of 2 vol hexane/isopropanol (1:1, vol/vol). Vitamin K metabolites were extracted by vortexing for 30 s followed by centrifugation at 2,000 g for 10 min. The organic phase was transferred to glass tubes and dried under a stream of N2 (N-Evap, Organomation Asso-ciates, Worcester, MA). The 
Results
Inhibition of microsomal y-carboxylation of glutamic acid.
Since previous work had shown that MTT is able to inhibit microsomal carboxylation of glutamic acid (3, 4) , concentration inhibition curves for this effect were established for the intact MTT-containing antibiotics, cefamandole and moxalactam, and compared to the previous results obtained with M4TT Npithi-r mnYnlnrtnm nnr r,-fhmon~ndn inhihitPAov_-d (Fig. 2) . Addition of MT boxylation of glutamic acid shown in Fig. 2 with an IC5 0.6 mM. The effect of GSSG upon shown in Table I (Fig. 4) (Fig. 3 B) . In addition, both cefamandole and moxalacstr. Akin dos-rIetedincreasetin tam significantly increased bile flow: from 1.36±0.22 to ration and efflux (Fig. 3 A) GSH in supporting this reaction. Similar findings have been reported for the human liver enzyme (18) . Some activity could be detected at concentrations of DTT as low as 0.05 mM.
Preincubation of solubilized microsomes for 2 minutes with GSSG blocked the reduction of vitamin K epoxide at 0.1 mM DTT in a concentration-dependent manner (Fig. 5) . Under these conditions inhibition was detected at concentrations as low as 0.01 mM GSSG. At a higher concentration of DTT (1.0 mM), a higher concentration of GSSG was required to achieve the same degree of inhibition.
In separate experiments, 0.1 mM GSSG reduced the activity of epoxide reductase to 57% of control in the presence of 0.1 mM DTT. Further addition of DTT to achieve a final concentration of 1.1 mM DTT restored activity to 95% of control, whereas addition of buffer did not alter the inhibition observed at 30 min.
To determine whether GSSG causes nonenzymatic oxidation of DTT, thereby depleting a necessary cofactor for vitamin K epoxide reductase; oxidation of DTT was monitored spectrophotometrically as described by Cleland (21) . In the presence of 0.2 mM GSSG, 50% of0.1 mM DTT was oxidized over 30 min. At this concentration of GSSG, the activity of epoxide reductase was completely inhibited (Fig. 5) . If the observed inhibition of the reductase was due entirely to a decrease in the concentration of reduced DTT, one would expect to find no activity in the presence of0.05 mM DTT. However, activity of the reductase was 63% of that observed in the presence of 0.1 mM DTT. These observations suggest that, although GSSG may cause nonenzymatic oxidation of DTT, its effects upon the activity of epoxide reductase are not due entirely to this mechanism.
Discussion
The results of this study provide new insight into how MTT, a thiocarbamide side group of several fl-lactam antibiotics, may cause hypoprothrombinemia. Administration of MTT-containing antibiotics can produce hypoprothrombinemia (20) and alter vitamin K metabolism in the rat (22) . Vitamin K The increased hepatic concentration and biliary effilux of GSSG after administration of MTT and cefamandole demonstrated in these studies is consistent with previously reported findings with other thiocarbamides (8) . Therefore, we investigated the possibility that GSSG, an endogenous disulfide, might interfere with reduction ofvitamin K epoxide or directly inhibit carboxylation of glutamic acid or both. Although we did not find evidence for direct inhibition of carboxylation by GSSG, our results show that GSSG can inhibit reduction of vitamin K1,2,3-epoxide in a concentration-dependent manner. The fact that there is less inhibition seen when GSSG is incubated in the presence of higher concentrations of DTT suggests that the thiol/disulfide ratio rather than the absolute concentration of GSSG may be an important determinant of the activity of the vitamin K epoxide reductase.
The concentrations of GSSG shown to inhibit reduction of vitamin K epoxide are pharmacologically relevant, occurring as low as 10-25 AM. With increasing thiol concentration, inhibition by GSSG was prevented, perhaps through reduction of mixed disulfides of glutathione and protein. Since the physiologically active thiol in this reaction is unknown, it is difficult to extrapolate this finding to in vivo conditions. Regulation of enzyme activity by the thiol/disulfide ratio has been proposed for several enzymes. Although the regulation of enzymes by physiologic alterations in thiol/disulfide status is a subject of controversy (12) , the magnitude of changes in hepatic content of GSSG such as occurs after pharmacologic challenges may be sufficient to alter enzyme activity through such a mechanism. Recent work has also suggested that cellular resistance to cancer chemotherapeutic drugs may be related to alterations in the cellular glutathione redox state (23) .
Glutathione can prevent, but not reverse, inhibition of ycarboxylation in vitro by MTT (using vitamin K, as a cofactor) even when MTT is added in 40-fold excess (4). These findings also suggest that the thiol status may be important in maintaining activity ofan enzyme(s) involved in 'y-carboxylation or the vitamin K cycle. Alternatively, GSH may react directly with a metabolite of MTT to prevent inhibition under in vitro conditions. Rapid oxidation ofGSH to GSSG is likely to lower hepatic levels of GSH allowing MTT-related inhibition of -ycarboxylation in vivo. This alteration in the thiol/disulfide ratio could indirectly enhance sensitivity of an enzyme to MTT in vivo. The observation that MTT containing antibiotics as well as MTT cause a disulfiram effect (24) suggests this may occur, since disulfiram reacts with critical sulfhydryl groups on aldehyde dehydrogenase, resulting in loss of activity which can be prevented by thiols (25) . Disulfiram has also been shown to inhibit both y-carboxylation of glutamic acid residues (4) and reduction of vitamin K, to the hydroquinone form (22) . Furthermore, there is evidence that the disulfiramlike inhibition of aldehyde dehydrogenase by MTT is caused by a more reactive metabolite of MTT (26, 27) .
It is ofinterest that lack of oral intake of food is considered a clinical risk factor for cephalosporin-associated hypoprothrombinemia (1). Although depletion of vitamin K stores has been postulated to explain this enhanced susceptibility, it seems equally attractive to speculate that decreased glutathione levels owing to fasting (28) are important in pathogenesis. At lower hepatic concentrations of GSH, oxidation ofGSH to GSSG would result in a GSSG/GSH ratio which would be considerably higher than under normal conditions. In some patients, cephalosporin-associated hypoprothrombinemia is reversible within 24 h after administration of vitamin K1 (1) . This response is consistent with inhibition of the reduction of vitamin K epoxide, since large doses of vitamin K, would overcome the requirement for the intact recycling of vitamin K. However, in other patients, a much longer time is required for reversal of this effect. In the latter situation, impaired reduction of vitamin K epoxide alone would be an inadequate explanation for these findings. Direct inhibition of -y-carboxylation of glutamic acid residues due to a metabolite of MTT would offer a more satisfactory explanation.
In summary, the results presented here show that (a) administration of MTT-containing antibiotics alters both the reduction of vitamin K1 ,2,3-epoxide and the thiol redox ratio in rats in vivo, and (b) GSSG can inhibit the microsomal reduction of vitamin K1,2,3-epoxide in vitro. These observations suggest that the hypoprothrombinemia occurring after administration ofMTT-containing antibiotics may be due, in part, to an indirect effect on vitamin K metabolism resulting from oxidation of GSH to GSSG during hepatic metabolism of MTT.
